AngioDynamics Xcela Port Lawsuit Alleges Infection, Migration Caused by Defective Catheter

A Delaware resident has initiated a product liability action in federal court in California against AngioDynamics Inc. and Navilyst Medical Inc., manufacturers of implantable port catheters. The plaintiff alleges that the Xcela port catheter device she received was unreasonably dangerous and defectively designed.

According to the complaint, the plaintiff developed chest wall cellulitis, which led to the discovery that her port catheter had migrated out of its proper position and required surgical removal. The lawsuit claims that the manufacturers failed to warn medical professionals and patients of known risks associated with these devices, including migration, fractures, and infections.

Port catheters are implanted medical devices designed to provide long-term venous access for chemotherapy, blood transfusions, and other intravenous treatments. The devices consist of a subcutaneous access port connected to a catheter. The plaintiff contends that AngioDynamics and other port manufacturers currently face hundreds of similar lawsuits alleging that their devices have caused harm to patients.

This is a curated brief from the PlaintiffWire news desk. Read the original report at AboutLawsuits.